Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

9 results
Display

The Efficacy of a Modified Chronomodulated Infusion of Oxaliplatin, 5-Fluorouracil and Leucovorin in Advanced Colorectal Cancer (Preliminary Data)

Park JY, Kim SY, Lee JJ, Yoon HJ, Cho KS

  • Cancer Res Treat.
  • 2004 Jun;36(3):199-204.
PURPOSE: To determine the efficacy and tolerability of a modified chronomodulated infusion of oxaliplatin, 5-fluorouracil (5-FU) and leucovorin in the treatment of advanced colorectal cancer. MATERIALS AND METHODS: Sixteen patients with...
Clinical Value of Cyclooxygenase-2 Expression in Human Breast Carcinoma

Ahn JH, Kim SB, Ahn SH, Gong GY, Ahn MJ, Kang YK, Lee JS, Kim WK

  • Cancer Res Treat.
  • 2004 Jun;36(3):192-198.
PURPOSE: To determine whether COX-2 expression is associated with clinicopathological parameters, including c-erb-B2 overexpression and angiogenesis, and the disease- free survival of patients with operable breast cancer. MATERIALS AND METHODS: Paraffin-embedded...
Expression of Cyclooxygenase (COX)-2 as a Prognostic Factor in Nasopharyngeal Cancer

Kim K, Wu HG, Park SW, Kim CJ, Park CI

  • Cancer Res Treat.
  • 2004 Jun;36(3):187-191.
PURPOSE: To evaluate the relationship between treatment failure and COX-2 expression in nasopharyngeal cancer patients treated with chemotherapy and radiotherapy. MATERIALS AND METHODS: The subjects of this study were 22 nasopharyngeal...
Combination Chemotherapy of Heptaplatin, Paclitaxel and 5-Fluorouracil in Patients with Advanced Gastric Cancer: a Pilot Study

Ahn MJ, Oh HS, Choi JH, Lee YY, Kim IS, Choi IY, Lee OY, Choi HS, Kwon SJ

  • Cancer Res Treat.
  • 2004 Jun;36(3):182-186.
PURPOSE: To evaluate the efficacy and toxicity of heptaplatin, paclitaxel, and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer. MATERIALS AND METHODS: Between July 2002 and September 2003, nineteen patients...
Predictive Value of Preoperative Serum CEA, CA19-9 and CA125 Levels for Peritoneal Metastasis in Patients with Gastric Carcinoma

Hwang GI, Yoo CH, Sohn BH, Shin JH, Park YL, Kim HD, Kim YS, Han WK, Pae WK

  • Cancer Res Treat.
  • 2004 Jun;36(3):178-181.
PURPOSE: Peritoneal metastasis is a crucial factor for the prognosis in gastric cancer, but its diagnosis is difficult before laparotomy. This study analyzed the usefulness of diagnostic imaging and various...
Combination of Gemcitabine and Cisplatin as First-Line Therapy in Advanced Non-Small-Cell Lung Cancer

Lee NS, Byun JH, Bae SB, Kim CK, Lee KT, Park SK, Won JH, Hong DS, Park HS

  • Cancer Res Treat.
  • 2004 Jun;36(3):173-177.
PURPOSE: The prognosis of patients with advanced non-small-cell lung cancer (NSCLC) is extremely poor. Many prospective randomized trials on patients with advanced NSCLC suggested systemic chemotherapy improves both the survival...
Expression of c-kit and p53 in Non-small Cell Lung Cancers

Yoo J, Kim CH, Song SH, Shim BY, Jeong YJ, Ahn MI, Kim SW, Cho DG, Jo MS, Cho KD, Cho HJ, Kim HK

  • Cancer Res Treat.
  • 2004 Jun;36(3):167-172.
PURPOSE: Increasing experimental evidence indicates that abnormal expression of c-kit may be implicated in the pathogenesis of a variety of solid tumors. It has been reported that over 70% of...
Lung Cancer Screening with Low-Dose Chest CT: Current Issues

Ahn MI

  • Cancer Res Treat.
  • 2004 Jun;36(3):163-166.
Computed tomography offers many advantages over routine radiographs in screening for lung cancer, and it is clear that low-dose spiral CT screening can more frequently find considerably smaller lung cancers...
Cyclooxygenase-2: A Potential Target in Human Cancer

Won JH

  • Cancer Res Treat.
  • 2004 Jun;36(3):161-162.
No abstract available.

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr